Drugs Made In America Acquisition (DMAA) Stock Chart & Stock Price History $10.26 -0.03 (-0.29%) As of 09/5/2025 03:50 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock Drugs Made In America Acquisition Stock Price Performance The Drugs Made In America Acquisition (DMAA) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 0.10%, reflecting recent market activity. As of the latest close, Drugs Made In America Acquisition traded at $10.26 with a market cap of $299.28 million and volume of 4,781 shares. Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.10%1 Month Performance-0.10% DMAA Stock Chart for Saturday, September, 6, 2025 DMAA Chart by TradingView Drugs Made In America Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025$10.26$10.26$10.26$10.264,781 shs$299.28 million09/04/2025$10.29$10.26-0.29%$10.27$10.264,449 shs$299.28 million09/03/2025$10.26$10.29+0.29%$10.29$10.29101 shs$300.17 million09/02/2025$10.25$10.26+0.10%$10.28$10.252,810 shs$299.28 million09/01/2025$10.25$10.25$10.25$10.251,023 shs$298.99 million08/29/2025$10.25$10.25$10.25$10.251,023 shs$298.99 million08/28/2025$10.26$10.25-0.10%$10.26$10.2541,402 shs$299.00 million08/27/2025$10.26$10.26$10.26$10.25103,440 shs$299.28 million08/26/2025$10.27$10.26-0.10%$10.28$10.2350,978 shs$299.28 million08/25/2025$10.27$10.27$10.28$10.221,507 shs$299.59 million Get the Latest News and Ratings for DMAA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025$10.27$10.27$10.27$10.241,371 shs$299.58 million08/21/2025$10.26$10.27+0.10%$10.27$10.241,371 shs$299.59 million08/20/2025$10.26$10.26$10.26$10.2625,820 shs$299.28 million08/19/2025$10.28$10.26-0.19%$10.26$10.26111 shs$299.28 million08/18/2025$10.27$10.28+0.10%$10.28$10.28112 shs$299.88 million08/15/2025$10.28$10.27-0.10%$10.27$10.27105 shs$299.59 million08/14/2025$10.25$10.28+0.29%$10.28$10.26883 shs$299.87 million08/13/2025$10.23$10.25+0.20%$10.28$10.257,773 shs$298.99 million08/12/2025$10.28$10.23-0.49%$10.28$10.23145,779 shs$298.42 million08/11/2025$10.26$10.28+0.19%$10.28$10.25521 shs$299.87 million08/08/2025$10.27$10.26-0.10%$10.26$10.26324 shs$299.28 million08/07/2025$10.27$10.27$10.28$10.264,347 shs$299.58 million08/06/2025$10.26$10.27+0.10%$10.27$10.26172,457 shs$299.59 million08/05/2025$10.27$10.26-0.10%$10.27$10.2677,011 shs$299.28 million Related Companies BRDG Stock Price Chart SAFE Stock Price Chart SBR Stock Price Chart DEA Stock Price Chart CSR Stock Price Chart PLYM Stock Price Chart FBRT Stock Price Chart PAX Stock Price Chart ORC Stock Price Chart UNIT Stock Price Chart Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAA) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAA Stock Alerts